Medtronic plans to separate from its diabetes business and launch it as an independent company—one that will count more than ...

While some analysts questioned why Medtronic would leave a fast-growing market, others backed the company’s plan to focus on ...

Finally, Medtronic remains an excellent dividend stock, and it recently announced yet another payout hike. The medical device ...

Medtronic plans to submit the 780G with Simplera Sync to the FDA. The approval of this combo could drive even more growth within this market for the company. That is why the FAST Graphs analyst ...

Medtronic aims to fully close the diabetes management loop Medtronic originally submitted the MiniMed 780G system for FDA approval in spring 2021, but the regulatory decision was delayed after the ...

Medtronic (NYSE:MDT) announced today that it intends to separate its Diabetes business into a new standalone company.

2023 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, is presenting a robust collection of new clinical and real-world data on the MiniMed™ 780G system.

The first shipments of the MiniMed 780G system are expected this summer with preorders beginning on May 15, 2023. The Food and Drug Administration (FDA) has approved the Medtronic MiniMed ™ 780G ...

Medtronic plc MDT presented new clinical and real-world data on the MiniMed 780G system at the 83rd American Diabetes Association Scientific Sessions. In April, the FDA approved Medtronic's ...

The US Food and Drug Administration (FDA) has granted approval for the use of Medtronic’s disposable Simplera Sync sensor with the MiniMed 780G system. The all-in-one sensor is said to eliminate ...

Medtronic plc’s MDT most advanced automated insulin delivery (AID) system, MiniMed 780G, was recently recognized by the Fast Company in the Best World-Changing Idea, North America category as ...

In its application to the Food and Drug Administration, Medtronic is seeking clearance for its MiniMed 780G pump as an alternate controller-enabled insulin pump. If approved, the pump would be ...